TNYA · Tenaya Therapeutics, Inc.
$0.70
+0.01 (+0.98%)
At close · Aug 21
Market Cap
$156.36M
Shares
224.23M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.70
Open$0.69
Day$0.69–0.72
52W close$0.55–2.10
Avg vol 30d1.9M
Short int22.0M · 9.8% float · 13.7d
Short vol54%
Last earningsMay 15, 2026
DataJul 2021–Aug 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Sep 3, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
−9%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
10%
near low
Momentum
relative strength
1-month return
−10%
trailing
6-month return
+22%
trailing
YTD return
−2%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +18 funds added
Insider flow
Distributing
Net -$21.0K over 90 days · 100% sells
Short interest
Falling
9.81% of float · ▼ -11.8% MoM · 13.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
101 holders — mid 3-yr range
Squeeze score
70
elevated · 0–100
Fundamentals
EPS growth
+55%
Y/Y
Free cash flow
$-68.9M
Balance sheet
$100.5M
net cash
Quant / Vol
risk profile
Volatility
102%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
10%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +18 funds added
Insider flow
Distributing
Net -$21.0K over 90 days · 100% sells
Short interest
Falling
9.81% of float · ▼ -11.8% MoM · 13.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
101 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 10%
Range high $2
vs 200-day avg -16%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TNYA
this stock
Tenaya Therapeutics, Inc.
|
$156.36M | -2.1% | — | — | 9.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TNYA | -4.2% | -10.0% | +22.3% | -5.8% | -2.1% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -2.9% | -13.7% | +10.8% | -8.3% | -14.4% |
Key facts
CIK
1858848
CUSIP
87990A106
13F (30d)
87 filings
87 filers
Visit website
Investor relations